As of April 16, 2025, Oculis Holding AG (OCS) has a market cap of $0.86 billion USD. According to our data, Oculis Holding AG is ranked No.5241 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.86 B |
17.73%
|
Dec 31, 2024 | $0.73 B |
51.38%
|
Dec 29, 2023 | $0.48 B |
11.19%
|
Dec 30, 2022 | $0.43 B |
4.23%
|
Dec 31, 2021 | $0.42 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Alcon
ALC
|
$45.22 B |
-0.002 M
|
![]() Switzerland
|
![]() Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
![]() Canada
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Santen Pharmaceutical
4536.T
|
$3.33 B |
0.127 B
|
![]() Japan
|
![]() Glaukos
GKOS
|
$5.35 B |
0.000 M
|
![]() USA
|
![]() Kala Pharmaceuticals
KALA
|
$22.78 M |
0.000 M
|
![]() USA
|
![]() EyePoint Pharmaceuticals
EYPT
|
$0.39 B |
-0.000 M
|
![]() USA
|
![]() Clearside Biomedical
CLSD
|
$63.40 M |
0.000 M
|
![]() USA
|
![]() Omeros Corporation
OMER
|
$0.40 B |
-0.000 M
|
![]() USA
|
![]() Adverum Biotechnologies
ADVM
|
$67.19 M |
-0.000 M
|
![]() USA
|
![]() Aldeyra Therapeutics
ALDX
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Ocugen
OCGN
|
$0.20 B |
0.000 M
|
![]() USA
|
Market Cap | = | OCS Stock Price | * | OCS Shares Outstanding |
= | $17.93 | * | 48.00 M | |
= | $0.86 B |